Mindset Pharma Stock Cash Per Share
MSSTFDelisted Stock | USD 0.36 0.00 0.00% |
Mindset Pharma fundamentals help investors to digest information that contributes to Mindset Pharma's financial success or failures. It also enables traders to predict the movement of Mindset OTC Stock. The fundamental analysis module provides a way to measure Mindset Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mindset Pharma otc stock.
Mindset |
Mindset Pharma OTC Stock Cash Per Share Analysis
Mindset Pharma's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Mindset Pharma Cash Per Share | 0.09 X |
Most of Mindset Pharma's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mindset Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
CompetitionIn accordance with the recently published financial statements, Mindset Pharma has a Cash Per Share of 0.09 times. This is 97.93% lower than that of the Healthcare sector and 97.92% lower than that of the Biotechnology industry. The cash per share for all United States stocks is 98.2% higher than that of the company.
Mindset Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mindset Pharma's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Mindset Pharma could also be used in its relative valuation, which is a method of valuing Mindset Pharma by comparing valuation metrics of similar companies.Mindset Pharma is currently under evaluation in cash per share category among its peers.
Mindset Fundamentals
Return On Equity | -2.43 | |||
Return On Asset | -0.48 | |||
Profit Margin | (1.64) % | |||
Operating Margin | (1.33) % | |||
Current Valuation | 19.22 M | |||
Shares Outstanding | 95.25 M | |||
Shares Owned By Insiders | 9.00 % | |||
Shares Owned By Institutions | 0.88 % | |||
Price To Book | 28.87 X | |||
Price To Sales | 4.83 X | |||
Revenue | 3.91 M | |||
Gross Profit | 3.91 M | |||
EBITDA | (16.53 M) | |||
Net Income | (16.61 M) | |||
Cash And Equivalents | 8.71 M | |||
Cash Per Share | 0.09 X | |||
Total Debt | 171.79 K | |||
Debt To Equity | 0.12 % | |||
Current Ratio | 1.18 X | |||
Book Value Per Share | 0.01 X | |||
Cash Flow From Operations | 385.56 K | |||
Earnings Per Share | (0.19) X | |||
Target Price | 5.02 | |||
Beta | -0.28 | |||
Market Capitalization | 20.95 M | |||
Total Asset | 9.77 M | |||
Z Score | 69.3 | |||
Net Asset | 9.77 M |
About Mindset Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mindset Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mindset Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mindset Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Mindset OTC Stock
If you are still planning to invest in Mindset Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mindset Pharma's history and understand the potential risks before investing.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world |